Hua Medicine (Shanghai) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,023	1,140	1,461	490.63	675.24	1,032
Cash & Short-Term Investments	1,023	1,140	1,461	490.63	675.24	1,032
Cash Growth	-23.61%	-21.98%	197.74%	-27.34%	-34.58%	-6.65%
Accounts Receivable	80.05	34.39	0.98	12.94	-	-
Other Receivables	10.6	22.18	15.81	408.96	9.7	9.23
Receivables	90.65	56.57	16.79	421.9	9.7	9.23
Inventory	126.33	126.7	67.87	18.46	-	-
Other Current Assets	2.31	13.48	27	9.27	19.66	3.96
Total Current Assets	1,242	1,336	1,572	940.26	704.6	1,045
Property, Plant & Equipment	118.13	129.66	114.54	139.71	156.6	123.52
Other Intangible Assets	24.33	26.07	28.57	31.95	9.03	3.39
Other Long-Term Assets	35.47	35.07	9.79	9.58	33.33	26.34
Total Assets	1,420	1,527	1,725	1,121	903.55	1,199
Accounts Payable	46.89	63.72	51.63	20.98	23.79	25.82
Accrued Expenses	30.08	37.9	37.17	38.37	32.15	32.29
Short-Term Debt	-	-	-	33.92	-	-
Current Portion of Long-Term Debt	47	98.28	17.19	-	-	-
Current Portion of Leases	22.72	17.26	24.28	21.49	13.3	11.5
Current Unearned Revenue	1.02	98.04	98.38	53.86	13.85	14.25
Other Current Liabilities	11.78	15.07	23.38	19.76	23.8	22.69
Total Current Liabilities	159.49	330.27	252.03	188.39	106.88	106.55
Long-Term Debt	165.86	138.74	106.84	-	-	-
Long-Term Leases	35.47	45.91	19.44	42.17	58.23	69.21
Long-Term Unearned Revenue	-	1,148	1,246	611.36	288.11	290.27
Total Liabilities	360.82	1,663	1,624	841.92	453.22	466.03
Common Stock	7.21	7.21	7.21	7.21	7.21	7.21
Additional Paid-In Capital	5,938	5,932	5,931	5,922	5,910	5,900
Retained Earnings	-5,177	-6,361	-6,111	-5,900	-5,696	-5,370
Treasury Stock	-0.47	-0.49	-0.51	-0.58	-0.63	-0.69
Comprehensive Income & Other	291.48	286.43	274.5	250.96	229.63	196.54
Total Common Equity	1,059	-135.47	101.15	279.58	450.33	732.5
Shareholders' Equity	1,059	-135.47	101.15	279.58	450.33	732.5
Total Liabilities & Equity	1,420	1,527	1,725	1,121	903.55	1,199
Total Debt	271.05	300.18	167.75	97.58	71.53	80.72
Net Cash (Debt)	751.74	839.57	1,293	393.05	603.71	951.38
Net Cash Growth	-29.51%	-35.07%	228.98%	-34.89%	-36.54%	-6.33%
Net Cash Per Share	0.76	0.86	1.32	0.41	0.63	1.00
Filing Date Shares Outstanding	986.99	983.66	980.52	970.11	963.55	953.98
Total Common Shares Outstanding	986.99	983.66	980.52	970.11	963.55	953.98
Working Capital	1,083	1,006	1,320	751.87	597.72	938.73
Book Value Per Share	1.07	-0.14	0.10	0.29	0.47	0.77
Tangible Book Value	1,035	-161.53	72.58	247.63	441.31	729.11
Tangible Book Value Per Share	1.05	-0.16	0.07	0.26	0.46	0.76
Machinery	-	27.33	25.49	23.46	21.61	20.24
Construction In Progress	-	24.54	22.4	21.3	18.92	0.85
Leasehold Improvements	-	44.15	43.88	43.33	40.06	39.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.